{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:54:15Z","timestamp":1792108455988,"version":"4.4.0"},"reference-count":188,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006190","name":"VHA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jhep.2020.01.017","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T15:59:04Z","timestamp":1580227144000},"page":"1003-1027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4928-3681","authenticated-orcid":false,"given":"Jasmohan S.","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-3188","authenticated-orcid":false,"given":"Alexander","family":"Khoruts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.01.017_bib1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.01.017_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","article-title":"Targeting the gut-liver axis in liver disease","volume":"67","author":"Wiest","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cgh.2018.09.017","article-title":"Microbiome 101: studying, analyzing, and interpreting gut microbiome data for clinicians","volume":"17","author":"Allaband","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cgh.2018.08.008","article-title":"Altered microbiome in patients with cirrhosis and complications","volume":"17","author":"Acharya","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17474124.2019.1543587","article-title":"Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?","volume":"13","author":"Hatton","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2020.01.017_bib8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.14309\/ajg.0000000000000286","article-title":"Fecal microbiota transplant: a rose by any other name","volume":"114","author":"Khoruts","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.01.017_bib10","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2020.01.017_bib11","doi-asserted-by":"crossref","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","article-title":"Colonic microbiome is altered in alcoholism","volume":"302","author":"Mutlu","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.01.017_bib12","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/acer.13498","article-title":"Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis","volume":"41","author":"Bajaj","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2020.01.017_bib13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41467-017-00796-x","article-title":"Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus","volume":"8","author":"Llorente","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2020.01.017_bib15","doi-asserted-by":"crossref","first-page":"694629","DOI":"10.1155\/2012\/694629","article-title":"Microbial translocation in chronic liver diseases","volume":"2012","author":"Pinzone","year":"2012","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.jhep.2020.01.017_bib16","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2020.01.017_bib17","doi-asserted-by":"crossref","first-page":"j831","DOI":"10.1136\/bmj.j831","article-title":"The role of the microbiome in human health and disease: an introduction for clinicians","volume":"356","author":"Young","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2020.01.017_bib18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a\u00a0connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae","volume":"30","author":"Yuan","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2020.01.017_bib21","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/hep.28829","article-title":"Changes in blood microbiota profiles associated with liver fibrosis in obese patients: a pilot analysis","volume":"64","author":"Lelouvier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2019-318811","article-title":"Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease","author":"Sookoian","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib23","article-title":"Response to: \u2018Circulating microbiome in blood of different circulatory compartments' by Schierwagen et\u00a0al","author":"Hornung","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cmet.2019.08.002","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"30","author":"Loomba","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2020.01.017_bib25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.017_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Wei","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis","volume":"66","author":"Ruhlemann","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib29","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib30","doi-asserted-by":"crossref","first-page":"e0182924","DOI":"10.1371\/journal.pone.0182924","article-title":"Bile microbiota in primary sclerosing cholangitis: impact on disease progression and development of biliary dysplasia","volume":"12","author":"Pereira","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.01.017_bib31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/cid\/ciy205","article-title":"Gut dysbiosis associated with hepatitis C virus infection","volume":"67","author":"Inoue","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2020.01.017_bib32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/17474124.2017.1343663","article-title":"Gut microbiota changes and chronic hepatitis C virus infection","volume":"11","author":"Preveden","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/liv.13485","article-title":"Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls","volume":"38","author":"Heidrich","year":"2018","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.017_bib34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/apt.13732","article-title":"HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients","volume":"44","author":"Bajaj","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.01.017_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00248-010-9801-8","article-title":"Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients","volume":"61","author":"Lu","year":"2011","journal-title":"Microb Ecol"},{"key":"10.1016\/j.jhep.2020.01.017_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1471-230X-13-175","article-title":"Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach","volume":"13","author":"Wei","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcmgh.2019.04.016","article-title":"Gut microbiota as biosensors in patients with cirrhosis","volume":"8","author":"Bajaj","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib39","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","article-title":"Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis","volume":"139","author":"Arvaniti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.01.017_bib40","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/hep.29623","article-title":"The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2020.01.017_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.14949","article-title":"Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis","volume":"48","author":"Ciocan","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.01.017_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1040319","article-title":"Bacterial infections, sepsis, and multiorgan failure in cirrhosis","volume":"28","author":"Tandon","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.01.017_bib45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/femsre\/fuz002","article-title":"Lipopolysaccharide structures of Gram-negative populations in the gut microbiota and effects on host interactions","volume":"43","author":"Di Lorenzo","year":"2019","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jhep.2020.01.017_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2020.01.017_bib47","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41395-018-0085-9","article-title":"Proton pump inhibitor initiation and withdrawal affects gut microbiota and readmission risk in cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib48","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature14851","article-title":"Decompensated cirrhosis and microbiome interpretation","volume":"525","author":"Bajaj","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2020.01.017_bib49","doi-asserted-by":"crossref","first-page":"34055","DOI":"10.1038\/srep34055","article-title":"Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.01.017_bib50","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib51","doi-asserted-by":"crossref","first-page":"G675","DOI":"10.1152\/ajpgi.00152.2012","article-title":"Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation","volume":"303","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"12","key":"10.1016\/j.jhep.2020.01.017_bib52","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.cgh.2019.03.028","article-title":"Alterations in skin microbiomes of patients with cirrhosis","volume":"17","author":"Bajaj","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib53","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib54","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/ajg.2014.264","article-title":"Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization","volume":"109","author":"Patidar","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib55","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.28696","article-title":"Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice","volume":"64","author":"Kang","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11011-011-9250-1","article-title":"Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy","volume":"26","author":"Sarma","year":"2011","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2020.01.017_bib57","doi-asserted-by":"crossref","first-page":"26800","DOI":"10.1038\/srep26800","article-title":"Impaired gut-liver-brain axis in patients with cirrhosis","volume":"6","author":"Ahluwalia","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.01.017_bib58","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/ajg.2013.221","article-title":"Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing","volume":"108","author":"Zhang","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.017_bib59","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2018.07.022","article-title":"Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis","volume":"17","author":"Bajaj","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcmgh.2019.04.008","article-title":"Predicting clinical outcomes of cirrhosis patients with hepatic encephalopathy from the fecal microbiome","volume":"8","author":"Sung","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib61","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1172\/JCI79214","article-title":"Engineering the gut microbiota to treat hyperammonemia","volume":"125","author":"Shen","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2020.01.017_bib62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00004836-200308000-00014","article-title":"Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal","volume":"37","author":"Zullo","year":"2003","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib63","doi-asserted-by":"crossref","first-page":"G661","DOI":"10.1152\/ajpgi.00194.2019","article-title":"Posttraumatic stress disorder is associated with altered gut microbiota that modulates cognitive performance in veterans with cirrhosis","volume":"317","author":"Bajaj","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.01.017_bib64","doi-asserted-by":"crossref","DOI":"10.4161\/gmic.2.2.15416","article-title":"Diversity of the autochthonous colonic microbiota","volume":"2","author":"Nava","year":"2011","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhep.2020.01.017_bib65","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1038\/ncomms8735","article-title":"Microbiota and host determinants of behavioural phenotype in maternally separated mice","volume":"6","author":"De Palma","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2020.01.017_bib66","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2020.01.017_bib67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11011-012-9303-0","article-title":"A\u00a0longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy","volume":"27","author":"Bajaj","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhep.2020.01.017_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2020.01.017_bib69","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhep.2020.01.017_bib70","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhep.2020.01.017_bib71","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2020.01.017_bib72","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.30304","article-title":"Proton pump inhibitors are associated with minimal and overt hepatic encephalopathy and increased mortality in patients with cirrhosis","volume":"70","author":"Nardelli","year":"2019","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jhep.2020.01.017_bib73","doi-asserted-by":"crossref","first-page":"G951","DOI":"10.1152\/ajpgi.00268.2014","article-title":"Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function","volume":"307","author":"Bajaj","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.01.017_bib74","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41395-018-0085-9","article-title":"Proton pump inhibitor initiation and withdrawal affects gut microbiota and readmission risk in cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12876-017-0683-9","article-title":"Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration","volume":"17","author":"Sarangi","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib76","first-page":"547","article-title":"Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: a multicenter, randomized controlled trial","volume":"20","author":"Wang","year":"2019","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.jhep.2020.01.017_bib77","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.01.017_bib78","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1038\/ctg.2016.44","article-title":"Rifaximin exerts beneficial effects independent of its ability to alter microbiota composition","volume":"7","author":"Kang","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib79","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1499-3872(11)60124-0","article-title":"Changes of gut bacteria and immune parameters in liver transplant recipients","volume":"11","author":"Wu","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jhep.2020.01.017_bib80","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/ajt.14661","article-title":"Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice","volume":"18","author":"Zhang","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2020.01.017_bib81","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/lt.24754","article-title":"Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis","volume":"23","author":"Bajaj","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2020.01.017_bib82","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1038\/s41467-019-12633-4","article-title":"Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation","volume":"10","author":"Annavajhala","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2020.01.017_bib83","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/lt.25046","article-title":"Alterations in gut microbial function following liver transplant","volume":"24","author":"Bajaj","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2020.01.017_bib84","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib85","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","article-title":"A\u00a0gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"Caussy","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2020.01.017_bib86","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.21515","article-title":"Testing for minimal hepatic encephalopathy in the United States: an AASLD survey","volume":"45","author":"Bajaj","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib87","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.14309\/ajg.0000000000000102","article-title":"Specific gut and salivary microbiota patterns are linked with different cognitive testing strategies in minimal hepatic encephalopathy","volume":"114","author":"Bajaj","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib88","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib89","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/hep.27819","article-title":"Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy","volume":"62","author":"Bajaj","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.017_bib90","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/gutjnl-2016-313170","article-title":"Fungal dysbiosis in cirrhosis","volume":"67","author":"Bajaj","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib91","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98019","article-title":"Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis","volume":"3","author":"Bajaj","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhep.2020.01.017_bib92","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/liv.14097","article-title":"Characterization of the circulating microbiome in acute-on-chronic liver failure associated with hepatitis B","volume":"39","author":"Zhang","year":"2019","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.jhep.2020.01.017_bib93","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/jgh.12932","article-title":"Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality","volume":"30","author":"Chen","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib94","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2018.07.022","article-title":"Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis","volume":"17","author":"Bajaj","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib95","doi-asserted-by":"crossref","first-page":"e000315","DOI":"10.1136\/bmjgast-2019-000315","article-title":"High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study","volume":"6","author":"Duseja","year":"2019","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib96","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.3748\/wjg.v19.i40.6911","article-title":"Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis","volume":"19","author":"Ma","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib97","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","article-title":"Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"392","author":"Sanyal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.01.017_bib98","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/apt.14540","article-title":"Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis","volume":"47","author":"Damman","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.01.017_bib99","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1053\/j.gastro.2014.08.031","article-title":"Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial","volume":"147","author":"Dhiman","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.01.017_bib100","first-page":"854","article-title":"Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis","volume":"44","author":"Eiseman","year":"1958","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2020.01.017_bib101","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.anaerobe.2018.07.005","article-title":"Clostridium difficile and Clostridioides difficile: two validly published and correct names","volume":"52","author":"Oren","year":"2018","journal-title":"Anaerobe"},{"key":"10.1016\/j.jhep.2020.01.017_bib102","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile\u2013more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.01.017_bib103","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.01.017_bib104","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/M16-2733","article-title":"Increasing incidence of multiply recurrent Clostridium difficile Infection in the United States: a cohort study","volume":"167","author":"Ma","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2020.01.017_bib105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MCG.0b013e3181c87e02","article-title":"Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea","volume":"44","author":"Khoruts","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib106","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation","volume":"9","author":"Bakken","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib107","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jhep.2020.01.017_bib108","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1111\/trf.15422","article-title":"Banking feces: a new frontier for public blood banks?","volume":"59","author":"Jorgensen","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.jhep.2020.01.017_bib109","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.1224203","article-title":"The application of ecological theory toward an understanding of the human microbiome","volume":"336","author":"Costello","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jhep.2020.01.017_bib110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.017_bib111","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cgh.2014.11.014","article-title":"Development of fecal microbiota transplantation suitable for mainstream medicine","volume":"13","author":"Khoruts","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib112","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ajg.2011.482","article-title":"Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection","volume":"107","author":"Hamilton","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib113","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial","volume":"315","author":"Lee","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.01.017_bib114","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40168-015-0070-0","article-title":"Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"3","author":"Weingarden","year":"2015","journal-title":"Microbiome"},{"key":"10.1016\/j.jhep.2020.01.017_bib115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2016.11.010","article-title":"Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection","volume":"152","author":"Ott","year":"2017","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.jhep.2020.01.017_bib116","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.2014.13875","article-title":"Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection","volume":"312","author":"Youngster","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.01.017_bib117","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial","volume":"318","author":"Kao","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.01.017_bib118","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40121-018-0189-y","article-title":"Comparison of different strategies for providing fecal microbiota transplantation to treat patients with recurrent Clostridium difficile infection in two English hospitals: a review","volume":"7","author":"Goldenberg","year":"2018","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jhep.2020.01.017_bib119","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040931","article-title":"Dietary factors in sulfur metabolism and pathogenesis of ulcerative colitis","volume":"11","author":"Teigen","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jhep.2020.01.017_bib121","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.01.017_bib122","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrmicro3552","article-title":"Gut biogeography of the bacterial microbiota","volume":"14","author":"Donaldson","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jhep.2020.01.017_bib123","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chom.2019.08.011","article-title":"Regional diversity of the gastrointestinal microbiome","volume":"26","author":"Martinez-Guryn","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2020.01.017_bib124","doi-asserted-by":"crossref","first-page":"137rv136","DOI":"10.1126\/scitranslmed.3004244","article-title":"Therapeutic modulation of microbiota-host metabolic interactions","volume":"4","author":"Holmes","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2020.01.017_bib125","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.celrep.2019.04.023","article-title":"Comparison of co-housing and littermate methods for microbiota standardization in mouse models","volume":"27","author":"Robertson","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2020.01.017_bib126","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"issue":"10075","key":"10.1016\/j.jhep.2020.01.017_bib127","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.01.017_bib128","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.01.017_bib129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.jhep.2020.01.017_bib130","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.molmet.2016.06.002","article-title":"Causality of small and large intestinal microbiota in weight regulation and insulin resistance","volume":"5","author":"Scheithauer","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.jhep.2020.01.017_bib131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12916-016-0698-z","article-title":"Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"14","author":"Jalanka","year":"2016","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.017_bib132","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ajg.2017.6","article-title":"Successful resolution of recurrent Clostridium difficile infection using freeze-dried, encapsulated fecal microbiota; pragmatic cohort study","volume":"112","author":"Staley","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.017_bib133","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/19490976.2017.1299310","article-title":"Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota","volume":"8","author":"Staley","year":"2017","journal-title":"Gut microbes"},{"key":"10.1016\/j.jhep.2020.01.017_bib134","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01586-19","article-title":"Durable long-term bacterial engraftment following encapsulated fecal microbiota transplantation to treat Clostridium difficile infection","volume":"10","author":"Staley","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.jhep.2020.01.017_bib135","doi-asserted-by":"crossref","first-page":"G310","DOI":"10.1152\/ajpgi.00282.2013","article-title":"Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection","volume":"306","author":"Weingarden","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.01.017_bib136","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1101\/gr.107987.110","article-title":"Reshaping the gut microbiome with bacterial transplantation and antibiotic intake","volume":"20","author":"Manichanh","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.jhep.2020.01.017_bib137","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/19490976.2017.1334034","article-title":"Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals","volume":"8","author":"Vujkovic-Cvijin","year":"2017","journal-title":"Gut microbes"},{"key":"10.1016\/j.jhep.2020.01.017_bib138","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/gutjnl-2014-307240","article-title":"Effects of bowel cleansing on the intestinal microbiota","volume":"64","author":"Jalanka","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib139","doi-asserted-by":"crossref","first-page":"e799","DOI":"10.1371\/journal.pone.0000799","article-title":"Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth","volume":"2","author":"Comeau","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.01.017_bib140","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/JB.188.7.2726-2729.2006","article-title":"beta-lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus aureus","volume":"188","author":"Maiques","year":"2006","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.jhep.2020.01.017_bib141","doi-asserted-by":"crossref","first-page":"e0148824","DOI":"10.1371\/journal.pone.0148824","article-title":"An integrated metabolomic and microbiome analysis identified specific gut microbiota associated with fecal cholesterol and coprostanol in Clostridium difficile infection","volume":"11","author":"Antharam","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.01.017_bib142","doi-asserted-by":"crossref","DOI":"10.1093\/femsec\/fiy133","article-title":"Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients","volume":"94","author":"Nusbaum","year":"2018","journal-title":"FEMS Microbiol Ecol"},{"key":"10.1016\/j.jhep.2020.01.017_bib143","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anaerobe.2018.04.001","article-title":"Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection","volume":"53","author":"Seekatz","year":"2018","journal-title":"Anaerobe"},{"key":"10.1016\/j.jhep.2020.01.017_bib144","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrgastro.2016.98","article-title":"Understanding the mechanisms of faecal microbiota transplantation","volume":"13","author":"Khoruts","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib145","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s40168-018-0549-6","article-title":"Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation","volume":"6","author":"Staley","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.jhep.2020.01.017_bib146","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","article-title":"Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features","volume":"174","author":"Zmora","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2020.01.017_bib147","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40168-017-0269-3","article-title":"Changes in microbial ecology after fecal microbiota transplantation for recurrent C.\u00a0difficile infection affected by underlying inflammatory bowel disease","volume":"5","author":"Khanna","year":"2017","journal-title":"Microbiome"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.017_bib148","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/19490976.2017.1279377","article-title":"Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease","volume":"8","author":"Newman","year":"2017","journal-title":"Gut microbes"},{"key":"10.1016\/j.jhep.2020.01.017_bib149","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cgh.2018.05.038","article-title":"Patients with cirrhosis require more fecal microbiota capsules to cure refractory and recurrent Clostridium difficile infections","volume":"17","author":"Pringle","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hep.28121","article-title":"Fecal microbiota transplantation in the management of hepatic encephalopathy","volume":"63","author":"Kao","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2020.01.017_bib151","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.30037","article-title":"Antibiotic-associated disruption of microbiota composition and function in cirrhosis is restored by fecal transplant","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.017_bib152","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","article-title":"Long-term outcomes after fecal microbiota transplantation in cirrhosis","volume":"156","author":"Bajaj","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.017_bib153","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/hep.30827","article-title":"Neuroinflammation in murine cirrhosis is dependent on the gut microbiome and is attenuated by fecal transplant","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2020.01.017_bib154","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"issue":"24","key":"10.1016\/j.jhep.2020.01.017_bib155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133410","article-title":"Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis","volume":"4","author":"Bajaj","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jhep.2020.01.017_bib156","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1056\/NEJMc1913670","article-title":"Donor screening for fecal microbiota transplantation","volume":"381","author":"Kassam","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.jhep.2020.01.017_bib157","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib158","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/hep.29008","article-title":"Faecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy","volume":"65","author":"Ren","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib159","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2020.01.017_bib160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12664-018-0859-4","article-title":"Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis","volume":"37","author":"Philips","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib161","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MAJ.0b013e318227e0b8","article-title":"Uncertainty and equipoise: at interplay between epistemology, decision making and ethics","volume":"342","author":"Djulbegovic","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jhep.2020.01.017_bib162","doi-asserted-by":"crossref","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","article-title":"Linkage of gut microbiome with cognition in hepatic encephalopathy","volume":"302","author":"Bajaj","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.01.017_bib163","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2020.01.017_bib164","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/hep.29791","article-title":"Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhep.2020.01.017_bib165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/liv.14256","article-title":"Metabolomics and microbial composition increase insight into the impact of dietary differences in cirrhosis","volume":"40","author":"Cox","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.01.017_bib166","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-14-40","article-title":"Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics","volume":"14","author":"Tuomisto","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib167","doi-asserted-by":"crossref","first-page":"18559","DOI":"10.1038\/srep18559","article-title":"Gut microbiota alterations can predict hospitalizations in cirrhosis independent of diabetes mellitus","volume":"5","author":"Bajaj","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.01.017_bib168","doi-asserted-by":"crossref","first-page":"25001","DOI":"10.1038\/srep25001","article-title":"Alteration of the serum microbiome composition in cirrhotic patients with ascites","volume":"6","author":"Santiago","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.01.017_bib169","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.1038\/s41598-018-26509-y","article-title":"Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy","volume":"8","author":"Iebba","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.01.017_bib170","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/hepr.13207","article-title":"Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: the microbiome, microbial markers and liver disease study","volume":"48","author":"Jacobs","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2020.01.017_bib171","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/gutjnl-2018-316227","article-title":"Circulating microbiome in blood of different circulatory compartments","volume":"68","author":"Schierwagen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.01.017_bib172","doi-asserted-by":"crossref","first-page":"e00068","DOI":"10.14309\/ctg.0000000000000068","article-title":"Dysbiosis of the duodenal mucosal microbiota is associated with increased small intestinal permeability in chronic liver disease","volume":"10","author":"Raj","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib173","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/j.cgh.2019.03.028","article-title":"Alterations in skin microbiomes of patients with cirrhosis","volume":"17","author":"Bajaj","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib174","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/jgh.12932","article-title":"Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality","volume":"30","author":"Chen","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.01.017_bib175","doi-asserted-by":"crossref","first-page":"e60042","DOI":"10.1371\/journal.pone.0060042","article-title":"Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy","volume":"8","author":"Bajaj","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.01.017_bib176","first-page":"162A","article-title":"Rifaximin improves brain edema and working memory in minimal hepatic encephalopathy: a prospective fMRI study","volume":"56","author":"Ahluwalia","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib177","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.3748\/wjg.v23.i47.8355","article-title":"Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity","volume":"23","author":"Kaji","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.01.017_bib178","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000494216","article-title":"Long-term effect of rifaximin with and without lactulose on the active bacterial assemblages in the proximal small bowel and faeces in patients with minimal hepatic encephalopathy","volume":"37","author":"Schulz","year":"2019","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2020.01.017_bib179","doi-asserted-by":"crossref","first-page":"12000","DOI":"10.1038\/s41598-019-48352-5","article-title":"Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis","volume":"9","author":"Horvath","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.01.017_bib180","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/apt.12695","article-title":"Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis","volume":"39","author":"Bajaj","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.01.017_bib181","first-page":"3596","article-title":"Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis","volume":"46","author":"Xia","year":"2018","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.jhep.2020.01.017_bib182","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/apt.13858","article-title":"Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis","volume":"45","author":"Acharya","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jhep.2020.01.017_bib183","doi-asserted-by":"crossref","first-page":"G824","DOI":"10.1152\/ajpgi.00230.2018","article-title":"Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis","volume":"315","author":"Bajaj","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2020.01.017_bib184","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.01.017_bib185","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.jhep.2020.01.017_bib186","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.01.017_bib187","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","article-title":"Long-term outcomes of fecal microbiota transplantation in patients with cirrhosis","volume":"156","author":"Bajaj","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.01.017_bib188","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s12664-018-0906-1","article-title":"Preliminary experience with single fecal microbiota transplant for treatment of recurrent overt hepatic encephalopathy-A case series","volume":"37","author":"Mehta","year":"2018","journal-title":"Indian J Gastroenterol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820300581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820300581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:39:19Z","timestamp":1759174759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820300581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":188,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0168827820300581"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.01.017","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}